Hutchison China MediTech Begins Colorectal Cancer Trial
LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said its majority-owned research and development company Hutchison MediPharma Ltd has initiated a Phase II clinical trial in colorectal cancer patients in China for fruquintinib. Fruquintinib is the company's investigational small Read More